


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.97%
-0.72%
+3.99%
+1.81%
-0.48%
META
Meta Platforms
$634.36
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
META Price Performance
$644.23 (-1.53%)
$717.55 (-11.59%)
$751.48 (-15.59%)
$676.49 (-6.23%)
META has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

META overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
META Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
META Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
GOOG
339.43
+1.85%
PINS
27.52
+2.61%
WB
11.07
-1.31%
TRIP
14.85
+0.13%
BIDU
147.25
-3.13%
What is META current stock price?
What are META stock strengths?
What is META Risk Level?
What is META market cap and volume?
What is META current Stock IQ?
Should I buy META stock right now?
Is META a Strong Buy right now?
What does a 'Strong Buy' rating mean for META?
What does a 'Strong Sell' rating mean for META?
What factors influence META's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.97%
-0.72%
+3.99%
+1.81%
-0.48%
META
Meta Platforms
Current Price
$634.36
META Stock IQ
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Outperform the market
Linked to META
GOOG
339.43
+1.85%
PINS
27.52
+2.61%
WB
11.07
-1.31%
TRIP
14.85
+0.13%
BIDU
147.25
-3.13%

META Price Performance
$644.23 (-1.53%)
$717.55 (-11.59%)
$751.48 (-15.59%)
$676.49 (-6.23%)
META Analysts Opinion
META Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Revenue increase YoY

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
META Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
META Street Sentiment is extremely bullish and have positive views on the near-term outlook
META has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Investors losing confidence

Average key support and resistance price levels
META Latest Analysis
Meta To Cut Over 10% Jobs In Reality Labs Division Amid AI Focus: Report. META) is reportedly planning to cut about 10% or more jobs in its Reality Labs division which includes the metaverse to focus more on next-generation AI initiatives.The Reality Labs division which currently employs around 15000 people is responsible for virtual reality headsets and a VR-based social network. The layoffs could be announced as early as Tuesday according to The New York Times.Meta did not immediately respond
Today
Meta to cut 10% of virtual reality staff to allocate more for AI -- report.
Mon Jan 12, 2026
Meta plans to cut 10% of Reality Labs staff amid AI shift - NYT.
Mon Jan 12, 2026
Meta Platforms Appoints Dina Powell McCormick As President And Vice Chairman . (RTTNews) - Meta Platforms Inc. (META) Monday announced the appointment of Dina Powell McCormick as the companys President and Vice Chairman.
Mon Jan 12, 2026
Why Did Oklo Stock Drop Today?. Key PointsOklos Meta news helped drive Oklo stock up 35% last week.
Mon Jan 12, 2026
Johnson & Johnson Therapy Delivers Strong Results In Colorectal Cancer Trial. On Saturday ) shared new longer follow-up results from the .The trial is evaluating Rybrevant (amivantamab-vmjw) in combination with FOLFOX or FOLFIRI chemotherapy for RAS/BRAF wild-type metastatic colorectal cancer.The company said that encouraging anti-tumor activity durable responses and low rates of treatment-related discontinuations observed in this study support further investigation in ongoing Phase 3 studies in
Mon Jan 12, 2026
Noteworthy Monday Option Activity: COF TSLA META. Looking at options trading activity among components of the S&.P 500 index there is noteworthy activity today in Capital One Financial Corp (Symbol: COF) where a total volume of 54568 contracts has been traded thus far today a contract volume which is representative of ap
Mon Jan 12, 2026
Meta Platforms unveils Meta Compute as it scales up in the AI infrastructure arms race.
Mon Jan 12, 2026
Meta appoints Dina Powell McCormick for new role receives Trump praise.
Mon Jan 12, 2026
Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026. Issued on behalf of Oncolytics Biotech Inc..com News Commentary – The oncology landscape is entering a high-velocity regulatory phase as genomics in cancer care expands toward a projected [1]. This massive growth is driven by the systematic integration of genotype-directed treatment pathways into standard medical practice. The precision medicine market is now on a trajectory to expand from [2]. This strate
Mon Jan 12, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
META Stock trends
META Stock performance
META Stock analysis
META investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.